Overview

Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose oral bioavailability of metformin HCI liquid 500 mg/5 mL of Ranbaxy with Glucophage® 1000 mg tablets of Bristol-Myers, USA following administration of a 1000 mg dose in healthy, adult, male and female volunteers under fasting conditions
Phase:
N/A
Details
Lead Sponsor:
Ranbaxy Laboratories Limited
Treatments:
Gabapentin
gamma-Aminobutyric Acid